Get these analyses to your inbox — https://axial.substack.com/
As always, if you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company — info@axialsprawl.com
Evotec is a drug discovery and development partnering company. Similar to Adimab, Evotec relies on partnerships to bring drugs through the clinic and to patients. However, Evotec relies on focused CRO-services instead of a unique invention. By integrating various types of experiments, Evotec has been able to achieve a certain scale in preclinical work to compel biopharma companies to strike up deals with Evotec making the transition to integrate clinical work. As a result, Evotec is pioneering the partnered drug discovery model.
However, this model was discovered mainly through trial-and-error. Evotec was founded in 1993 in Hamburg, Germany by Nobel Laureate Manfred Eigen (measuring chemical reactions), Charles Weissmann (cloning interferon) and a set of German scientists and entrepreneurs. Since its founding, the company has had a circuitous route to its current model. In 1996, the company collaborated with Novartis and SmithKlineBeecham to create a high-throughput screening service for the two partners called EVOscreen. In 2000, the company finally launched EVOscreen and began working with companies…
